AbbVie to test HIV drug for Covid-19 treatment
AbbVie has announced plans to evaluate HIV medicine Kaletra/Aluvia (lopinavir/ritonavir) as a treatment for Covid-19 caused by the novel
coronavirus.
AbbVie has announced plans to evaluate HIV medicine Kaletra/Aluvia (lopinavir/ritonavir) as a treatment for Covid-19 caused by the novel
coronavirus.